Clinical Trial

Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects

Name: Clinical Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of HSK31858 in Healthy Subjects — clinical trial record (NCT07134478)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a single-center, open-label, two-period, fixed-sequence clinical study to evaluate the effect of Rifampicin on the pharmacokinetics of HSK31858 in healthy subjects

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-08-14.

Trial Details

NCT Number	NCT07134478
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	Healthy Subjects
Enrollment	24 participants
Start Date	2024-10-28
Primary Completion	2024-12-24 (estimated)
Study Completion	2026-06-01 (estimated)
Updated on ClinicalTrials.gov	2025-12-31